Biomea Fusion, Inc. Share-based Payment Arrangement, Expense
Biomea Fusion, Inc. (BMEA) reported Share-based Payment Arrangement, Expense of $1.92 million for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2021-11-03
- Biomea Fusion, Inc. share-based payment arrangement, expense for the quarter ending 2021-09-30 was $1.92M.
- Biomea Fusion, Inc. share-based payment arrangement, expense for the quarter ending 2021-06-30 was $1.46M.
- Biomea Fusion, Inc. share-based payment arrangement, expense for the quarter ending 2021-03-31 was $919.00K.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month |
|---|---|---|---|
| 2021-09-30 | $1.92M 10-Q · filed 2021-11-03 | $3.38M derived: sum of 2 quarters · filed 2021-11-03 | $4.30M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $1.46M 10-Q · filed 2021-08-11 | $2.38M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $919.00K 10-Q · filed 2021-05-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |